Ramona Bloehs
University Hospital Heidelberg
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ramona Bloehs.
British Journal of Pharmacology | 2009
Jakob Gierten; Eckhard Ficker; Ramona Bloehs; K Schlömer; Sven Kathöfer; Eberhard P. Scholz; Edgar Zitron; Claudia Kiesecker; Alexander Bauer; Rüdiger Becker; Hugo A. Katus; Christoph A. Karle; Dierk Thomas
Two‐pore‐domain potassium (K2P) channels mediate potassium background (or ‘leak’) currents, controlling excitability by stabilizing membrane potential below firing threshold and expediting repolarization. Inhibition of K2P currents permits membrane potential depolarization and excitation. As expected for key regulators of excitability, leak channels are under tight control from a plethora of stimuli. Recently, signalling via protein tyrosine kinases (TKs) has been implicated in ion channel modulation. The objective of this study was to investigate TK regulation of K2P channels.
Biochemical and Biophysical Research Communications | 2009
Eberhard P. Scholz; Nora Niemer; David Hassel; Edgar Zitron; Heinrich F. Bürgers; Ramona Bloehs; Claudia Seyler; Daniel Scherer; Dierk Thomas; Sven Kathöfer; Hugo A. Katus; Wolfgang Rottbauer; Christoph A. Karle
The zebrafish is increasingly recognized as an animal model for the analysis of hERG-related diseases. However, functional properties of the zebrafish orthologue of hERG have not been analyzed yet. We heterologously expressed cloned ERG channels in Xenopus oocytes and analyzed biophysical properties using the voltage clamp technique. zERG channels conduct rapidly activating and inactivating potassium currents. However, compared to hERG, the half-maximal activation voltage of zERG current is shifted towards more positive potentials and the half maximal steady-state inactivation voltage is shifted towards more negative potentials. zERG channel activation is delayed and channel deactivation is accelerated significantly. However, time course of zERG conducted current under action potential clamp is highly similar to the human orthologue. In summary, we show that ERG channels in zebrafish exhibit biophysical properties similar to the human orthologue. Considering the conserved channel function, the zebrafish represents a valuable model to investigate human ERG channel related diseases.
British Journal of Pharmacology | 2009
Daniel Scherer; David Hassel; Ramona Bloehs; Edgar Zitron; Katharina von Löwenstern; Claudia Seyler; Dierk Thomas; Franziska M. Konrad; Heiner F. Bürgers; Gunnar Seemann; Wolfgang Rottbauer; Hugo A. Katus; Christoph A. Karle; Eberhard P. Scholz
Background and purpose: Atomoxetine is a selective noradrenaline reuptake inhibitor, recently approved for the treatment of attention‐deficit/hyperactivity disorder. So far, atomoxetine has been shown to be well tolerated, and cardiovascular effects were found to be negligible. However, two independent cases of QT interval prolongation, associated with atomoxetine overdose, have been reported recently. We therefore analysed acute and subacute effects of atomoxetine on cloned human Ether‐à‐Go‐Go‐Related Gene (hERG) channels.
Journal of Molecular Medicine | 2006
Claudia Kiesecker; Edgar Zitron; Daniel Scherer; Sonja Lueck; Ramona Bloehs; Eberhard P. Scholz; Marcus Pirot; Sven Kathöfer; Dierk Thomas; Volker A. W. Kreye; Johann Kiehn; Mathias M. Borst; Hugo A. Katus; Wolfgang Schoels; Christoph A. Karle
To elucidate the ionic mechanism of endothelin-1 (ET-1)-induced focal ventricular tachyarrhythmias, the regulation of IK1 and its main molecular correlates, Kir2.1, Kir2.2 and Kir2.3 channels, by ET-1 was investigated. Native IK1 in human atrial cardiomyocytes was studied with whole-cell patch clamp. Human endothelin receptors were coexpressed with human Kir2.1, Kir2.2 and Kir2.3 channels in Xenopus oocytes. Currents were measured with a two-microelectrode voltage clamp. In human cardiomyocytes, ET-1 induced a marked inhibition of IK1 that could be suppressed by the protein kinase C (PKC) inhibitor staurosporine. To investigate the molecular mechanisms underlying this regulation, we studied the coupling of ETA receptors to homomeric and heteromeric Kir2.1, Kir2.2 and Kir2.3 channels in the Xenopus oocyte expression system. ETA receptors coupled functionally to Kir2.2 and Kir2.3 channels but not to Kir2.1 channels. In Kir2.2 channels lacking functional PKC phosphorylation sites, the inhibitory effect was abolished. The inhibition of Kir2.3 currents could be suppressed by the PKC inhibitors staurosporine and chelerythrine. The coupling of ETA receptors to heteromeric Kir2.1/Kir2.2 and Kir2.2/Kir2.3 channels resulted in a strong inhibition of currents comparable with the effect observed in Kir2.2 homomers. Surprisingly, in heteromeric Kir2.1/Kir2.3 channels, no effect was observed. ET-1 inhibits human cardiac IK1 current via a PKC-mediated phosphorylation of Kir2.2 channel subunits and additional regulatory effects on Kir2.3 channels. This mechanism may contribute to the intrinsic arrhythmogenic potential of ET-1.
Journal of Molecular and Cellular Cardiology | 2011
Eberhard P. Scholz; F. Welke; N. Joss; Claudia Seyler; W. Zhang; Daniel Scherer; Mirko Völkers; Ramona Bloehs; Dierk Thomas; Hugo A. Katus; Christoph A. Karle; Edgar Zitron
The transient outward current I(to) is an important determinant of the early repolarization phase. I(to) and its molecular basis Kv4.3 are regulated by adrenergic pathways including protein kinase C. However, the exact regulatory mechanisms have not been analyzed yet. We here analyzed isoenzyme specific regulation of Kv4.3 and I(to) by PKC. Kv4.3 channels were expressed in Xenopus oocytes and currents were measured with double electrode voltage clamp technique. Patch clamp experiments were performed in isolated rat cardiomyocytes. Unspecific PKC stimulation with PMA resulted in a reduction of Kv4.3 current. Similar effects could be observed after activation of conventional PKC isoforms by TMX. Both effects were reversible by pharmacological inhibition of the conventional PKC isoenzymes (Gö6976). In contrast, activation of the novel PKC isoforms (ingenol) did not significantly affect Kv4.3 current. Whereas TMX-induced PKC activation was not attenuated inhibition of PKCβ, inhibition of PKCα with HBDDE prevented inhibitory effects of both PMA and TMX. Accordingly, stimulatory effects of PMA and TMX could be mimicked by the α-isoenzyme selective PKC activator iripallidal. Further evidence for the central role of PKCα was provided with the use of siRNAs. We found that PKCα siRNA but not PKCβ siRNA abolished the TMX induced effect. In isolated rat cardiomyocytes, PMA dependent I(to) reduction could be completely abolished by pharmacologic inhibition of PKCα. In summary we show that PKCα plays a central role in protein kinase C dependent regulation of Kv4.3 current and native I(to). These results add to the current understanding of isoenzyme selective ion channel regulation by protein kinases.
Biochemical and Biophysical Research Communications | 2008
Wei Zhang; Edgar Zitron; Ramona Bloehs; Sandra Müller-Krebs; Eberhard P. Scholz; Martin Zeier; Hugo A. Katus; Christoph A. Karle; Vedat Schwenger
The renal inward rectifier potassium channel Kir7.1 has been proposed to be functionally important for tubular K(+) recycling and secretion. This study investigated the regulation of Kir7.1 by PKA and PKC. Cloned human Kir7.1 channels were expressed heterologously in Xenopus oocytes. After pharmacological PKC activation, Kir7.1 currents were strongly inhibited. Co-application of PKC inhibitors attenuated this effect. Inactivation of PKC consensus sites also strongly attenuated the effect with a single site ((201)S) being essential for almost the total PKC sensitivity. In contrast, PKA activation induced an increase of Kir7.1 currents. This effect was absent in mutant Kir7.1 channels lacking PKA consensus site (287)S. In summary, this study demonstrates the dual regulation of Kir7.1 channel function by PKA and PKC. Structurally, these regulations depend on two key residues in the C-terminal channel domain ((Ser)201 for PKC and (Ser)287 for PKA).
Naunyn-schmiedebergs Archives of Pharmacology | 2010
Jakob Gierten; Eckhard Ficker; Ramona Bloehs; Patrick A. Schweizer; Edgar Zitron; Eberhard P. Scholz; Christoph A. Karle; Hugo A. Katus; Dierk Thomas
Naunyn-schmiedebergs Archives of Pharmacology | 2004
Edgar Zitron; Claudia Kiesecker; Eberhard P. Scholz; Sonja Lück; Ramona Bloehs; Sven Kathöfer; Dierk Thomas; Johann Kiehn; Volker A. W. Kreye; Hugo A. Katus; Wolfgang Schoels; Christoph A. Karle
Naunyn-schmiedebergs Archives of Pharmacology | 2010
Sabrina Obers; Ingo Staudacher; Eckhard Ficker; Adrienne T. Dennis; Ronald Koschny; Hande Erdal; Ramona Bloehs; Jana Kisselbach; Christoph A. Karle; Patrick A. Schweizer; Hugo A. Katus; Dierk Thomas
Biochemical and Biophysical Research Communications | 2007
Kamilla Kelemen; Claudia Kiesecker; Edgar Zitron; Alexander Bauer; Eberhard P. Scholz; Ramona Bloehs; Dierk Thomas; Johannes Greten; Andrew Remppis; Wolfgang Schoels; Hugo A. Katus; Christoph A. Karle